Results 81 to 90 of about 35,525 (153)

Expanding the Therapeutic Landscape: Sodium-Glucose Co-transporter 2 Inhibitors in Kidney Transplant Recipients. [PDF]

Cureus
Khan A, Ali MM, Hamer R.
europepmc   +1 more source

Sodium-glucose Co-transporter 2 Inhibitors on Body Composition in Lean Heart Failure With Preserved Ejection Fraction. [PDF]

Korean Circ J
Shimoya Y, Kagami K, Yuasa N, Tani Y, Harada T, Murakami T, Yamada E, Wada N, Ishii H, Obokata M.   +9 more
europepmc   +1 more source

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-Transporter-2 Inhibitors on Lean Body Mass in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]

Diabetes Metab Res Rev
Jobanputra R, Sargeant JA, Plekhanova T, James E, Almaqhawi A, Webb DR, Davies MJ, Yates T.   +7 more
europepmc   +1 more source

From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut Microbiota. [PDF]

Med Sci (Basel)
George MY, Gamal NK, Safwat K, Mamdouh M, AbdElFatah A, Atallah A, Cerchione C.   +6 more
europepmc   +1 more source

Sodium Glucose Co-Transporter-2 inhibitors in patients with systemic sclerosis with or without heart failure. [PDF]

Am J Med
Augusto SN, Kaelber DC, Chatterjee S, Tang WHW.   +3 more
europepmc   +1 more source

Real-world data on early initiation of sodium-glucose co-transporter-2 inhibitors in newly diagnosed heart failure with reduced ejection fraction. [PDF]

ESC Heart Fail
Kobayashi M, Monzo L, Baudry G, Hernandez G, Denquin O, Duarte K, Girerd N.   +6 more
europepmc   +1 more source

The Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Cardiovascular Outcomes in Heart Failure: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Maharaj A, Bidhesi S, Grover D, Raghunath P, Lutchmedial RN, Khan AS, Maharaj MA, Heera PV, Maharaj R, Sookhan C, Kanhai CD, Marshall C, Calder AA.   +12 more
europepmc   +1 more source

Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure

The American Journal of Medicine
openaire   +2 more sources

Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort study. [PDF]

Diabetes Obes Metab
Tsur A, Hamtzany O, Pollack R, Cahn A.
europepmc   +1 more source

Bioinformatics study of the pharmacological mechanism of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus and coronary heart disease based on network pharmacology. [PDF]

Medicine (Baltimore)
Yu S, Li J, Wu X, Lu S, Li C, Cheng H, Guo H, Yang P, Wang L.   +8 more
europepmc   +1 more source